Tucson, AZ, United States of America

Benjamin Alan Katchman

USPTO Granted Patents = 5 

Average Co-Inventor Count = 4.6

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Benjamin Alan Katchman

Introduction

Benjamin Alan Katchman is a notable inventor based in Tucson, AZ (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of viral pathogens. With a total of 5 patents to his name, Katchman has focused on developing methods that enhance the accuracy and efficiency of detecting infectious diseases.

Latest Patents

Katchman's latest patents include groundbreaking methods for detecting low levels of the COVID-19 virus. One of his notable inventions provides a method for detecting the presence of the COVID-19 virus in human or environmental samples. This method involves processing samples to obtain total nucleic acids, which are then used as a template in a reverse transcription-amplification reaction to obtain cDNA. This cDNA is utilized in a PCR amplification reaction to generate fluorescent COVID-19 virus-specific amplicons, which are detected by microarray hybridization near the lowest limit of detection. Additionally, this method allows for the detection of other respiratory disease-causing pathogens, including viruses, bacteria, and fungi, in a single assay.

Another significant patent focuses on a combinatorial microarray assay for clade variant detection. This method enables the detection of clade variants in the COVID-19 virus from human or environmental samples. The process involves obtaining total RNA from samples, which is then used as a template in a combined reverse transcription and amplification reaction to produce fluorescent COVID-19 virus amplicons. These amplicons are hybridized on a microarray with nucleic acid probes that can distinguish among various clade variants. The microarray is then imaged to detect the clade variant, generating an intensity distribution profile unique to each variant.

Career Highlights

Katchman is currently associated with Pathogendx, Inc., where he continues to innovate in the field of pathogen detection. His work has been instrumental in advancing diagnostic techniques that are crucial for public health.

Collaborations

Katchman collaborates with talented individuals such as Michael E Hogan and Candy Mavis Rivas, contributing to a dynamic research environment that fosters innovation.

Conclusion

Benjamin Alan Katchman is a distinguished inventor whose work in pathogen detection has made a significant impact on medical diagnostics. His innovative methods for detecting the COVID-19 virus and its variants demonstrate his commitment to advancing healthcare

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…